Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jun;84(11):1482–1487. doi: 10.1054/bjoc.2001.1739

Spatial variation and temporal trends of testicular cancer in Great Britain

M B Toledano 1, L Jarup 1, N Best 1, J Wakefield 1, P Elliott 1
PMCID: PMC2363674  PMID: 11384098

Abstract

Increases in testicular cancer incidence have been reported in several countries over a long period. Geographical variability has also been reported in some studies. We have investigated temporal trends and spatial variation of testicular cancer at ages 20–49 in Britain. Temporal trends in testicular cancer incidence were examined, 1974 to 1991 and in mortality, 1981–1997. Spatial variation in incidence was analysed across electoral wards, 1975 to 1991. We used Poisson regression to examine for regional and socio-economic effects and Bayesian mapping techniques to analyse small-area spatial variability. Incidence increased from 6.5 to 11.1 per 100 000 in men at ages 20–34, and from 5.6 to 9.7 per 100 000 in men at ages 35–49, while mortality declined by 50% in both age groups. Risks of testicular cancer varied across regional cancer registries, ranging from 0.79 (95% CI: 0.73–0.84) to 1.32 (95% CI: 1.25–1.38), and was higher in the most affluent compared with the most deprived areas. Analyses within 2 regions (one predominantly urban, the other predominantly rural) did not indicate any localized geographical clustering. The increasing incidence contrasted with a decreasing mortality over time in Great Britain, similar to that found in other countries. The higher risk in more affluent areas is not consistent with findings on social class at the individual level. The absence of any marked geographical variability at small area scale argues against a geographically varying environmental factor operating strongly in the aetiology of testicular cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: testicular cancer, temporal trends, geographical, epidemiology

Full Text

The Full Text of this article is available as a PDF (286.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Bergström R., Möhner M., Zatoński W., Storm H., Ekbom A., Tretli S., Teppo L., Ziegler H., Rahu M. Testicular cancer in nine northern European countries. Int J Cancer. 1994 Oct 1;59(1):33–38. doi: 10.1002/ijc.2910590108. [DOI] [PubMed] [Google Scholar]
  2. Bullard J., Coleman M. P., Robinson D., Lutz J. M., Bell J., Peto J. Completeness of cancer registration: a new method for routine use. Br J Cancer. 2000 Mar;82(5):1111–1116. doi: 10.1054/bjoc.1999.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chu K. C., Kramer B. S., Smart C. R. Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst. 1991 Nov 20;83(22):1636–1643. doi: 10.1093/jnci/83.22.1636. [DOI] [PubMed] [Google Scholar]
  4. Devesa S. S., Blot W. J., Stone B. J., Miller B. A., Tarone R. E., Fraumeni J. F., Jr Recent cancer trends in the United States. J Natl Cancer Inst. 1995 Feb 1;87(3):175–182. doi: 10.1093/jnci/87.3.175. [DOI] [PubMed] [Google Scholar]
  5. Devesa S. S., Silverman D. T., Young J. L., Jr, Pollack E. S., Brown C. C., Horm J. W., Percy C. L., Myers M. H., McKay F. W., Fraumeni J. F., Jr Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987 Oct;79(4):701–770. [PubMed] [Google Scholar]
  6. Ekbom A., Akre O. Increasing incidence of testicular cancer--birth cohort effects. APMIS. 1998 Jan;106(1):225–231. doi: 10.1111/j.1699-0463.1998.tb01340.x. [DOI] [PubMed] [Google Scholar]
  7. Ekbom A., Wicklund-Glynn A., Adami H. O. DDT and testicular cancer. Lancet. 1996 Feb 24;347(9000):553–554. doi: 10.1016/s0140-6736(96)91190-3. [DOI] [PubMed] [Google Scholar]
  8. Forman D., Møller H. Testicular cancer. Cancer Surv. 1994;19-20:323–341. [PubMed] [Google Scholar]
  9. Hatton M. Q., Paul J., Harding M., MacFarlane G., Robertson A. G., Kaye S. B. Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours. Eur J Cancer. 1995;31A(9):1487–1491. doi: 10.1016/0959-8049(95)00298-w. [DOI] [PubMed] [Google Scholar]
  10. Liu S., Wen S. W., Mao Y., Mery L., Rouleau J. Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health. 1999 May-Jun;90(3):176–180. doi: 10.1007/BF03404502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McKiernan J. M., Goluboff E. T., Liberson G. L., Golden R., Fisch H. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol. 1999 Aug;162(2):361–363. [PubMed] [Google Scholar]
  12. Møller H. Work in agriculture, childhood residence, nitrate exposure, and testicular cancer risk: a case-control study in Denmark. Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):141–144. [PubMed] [Google Scholar]
  13. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer. 1986 Apr;53(4):501–505. doi: 10.1038/bjc.1986.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pharris-Ciurej N. D., Cook L. S., Weiss N. S. Incidence of testicular cancer in the United States: has the epidemic begun to abate? Am J Epidemiol. 1999 Jul 1;150(1):45–46. doi: 10.1093/oxfordjournals.aje.a009916. [DOI] [PubMed] [Google Scholar]
  15. Potthoff R. F., Whittinghill M. Testing for homogeneity. I. The binomial and multinomial distributions. Biometrika. 1966 Jun;53(1):167–182. [PubMed] [Google Scholar]
  16. Senturia Y. D. The epidemiology of testicular cancer. Br J Urol. 1987 Oct;60(4):285–291. doi: 10.1111/j.1464-410x.1987.tb04970.x. [DOI] [PubMed] [Google Scholar]
  17. Sharpe R. M., Skakkebaek N. E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993 May 29;341(8857):1392–1395. doi: 10.1016/0140-6736(93)90953-e. [DOI] [PubMed] [Google Scholar]
  18. Sonnenschein C., Soto A. M. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):143–150. doi: 10.1016/s0960-0760(98)00027-2. [DOI] [PubMed] [Google Scholar]
  19. Sonneveld D. J., Schaapveld M., Sleijfer D. T., Meerman G. J., van der Graaf W. T., Sijmons R. H., Koops H. S., Hoekstra H. J. Geographic clustering of testicular cancer incidence in the northern part of The Netherlands. Br J Cancer. 1999 Dec;81(7):1262–1267. doi: 10.1038/sj.bjc.6690839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Swerdlow A. J., Huttly S. R., Smith P. G. Testicular cancer and antecedent diseases. Br J Cancer. 1987 Jan;55(1):97–103. doi: 10.1038/bjc.1987.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Swerdlow A. J., dos Santos Silva I., Reid A., Qiao Z., Brewster D. H., Arrundale J. Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer. 1998;77 (Suppl 3):1–54. doi: 10.1038/bjc.1998.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wanderås E. H., Tretli S., Fosså S. D. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer. 1995 Nov;31A(12):2044–2048. doi: 10.1016/0959-8049(95)00321-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES